Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies
- 27 January 2024
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 44 (4) , 1501-1544
Abstract
Diabetic foot ulcer (DFU) is one of the most costly and serious complications of diabetes. Treatment of DFU is usually challenging and new approaches are required to improve the therapeutic efficiencies. This review aims to update new and upcoming adjunctive therapies with noninvasive characterization for DFU, focusing on bioactive dressings, bioengineered tissues, mesenchymal stem cell (MSC) based therapy, platelet and cytokine‐based therapy, topical oxygen therapy, and some repurposed drugs such as hypoglycemic agents, blood pressure medications, phenytoin, vitamins, and magnesium. Although the mentioned therapies may contribute to the improvement of DFU to a certain extent, most of the evidence come from clinical trials with small sample size and inconsistent selections of DFU patients. Further studies with high design quality and adequate sample sizes are necessitated. In addition, no single approach would completely correct the complex pathogenesis of DFU. Reasonable selection and combination of these techniques should be considered.Keywords
Funding Information
- National Natural Science Foundation of China (81100581)
This publication has 268 references indexed in Scilit:
- Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment CapabilitiesPLOS ONE, 2012
- The Effect of Captopril on Impaired Wound Healing in Experimental DiabetesInternational Journal of Endocrinology, 2012
- Human Gingiva-Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound HealingStem Cells, 2010
- Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic miceLaboratory Investigation, 2010
- Propranolol improves cutaneous wound healing in streptozotocin-induced diabetic ratsEuropean Journal of Pharmacology, 2009
- Wound healing essentials: Let there be oxygenWound Repair and Regeneration, 2009
- Placenta-derived stem cells: new hope for cell therapy?Cytotechnology, 2008
- TOPICAL OXYGEN THERAPY INDUCES VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND IMPROVES CLOSURE OF CLINICALLY PRESENTED CHRONIC WOUNDSClinical and Experimental Pharmacology and Physiology, 2008
- Autologous Bone Marrow–Derived Cultured Mesenchymal Stem Cells Delivered in a Fibrin Spray Accelerate Healing in Murine and Human Cutaneous WoundsTissue Engineering, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006